Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNGMAP Sub-Study) (S1900A)
Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNGMAP Sub-Study) (S1900A)
Trial Category:
Lung
Phase
II
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
